Repositioning of clinically approved drug Bazi Bushen capsule for treatment of Aizheimer's disease using network pharmacology approach and in vitro experimental validation-MedSci.cn

Repositioning of clinically approved drug Bazi Bushen capsule for treatment of Aizheimer's disease using network pharmacology approach and in vitro experimental validation

Wang, TX; Chen, M; Li, HX; Ding, GY; Song, YF; Hou, B; Yao, B; Wang, ZX; Hou, YL; Liang, JQ; Wei, C; Jia, ZH

Liang, JQ; Wei, C; Jia, ZH (通讯作者)，Natl Key Lab Collateral Dis Res & Innovat Chinese, Shijiazhuang 050035, Peoples R China.;Liang, JQ; Wei, C; Jia, ZH (通讯作者)，Hebei Yiling Pharmaceut Res Inst, Key Lab State Adm TCM Cardiocerebral Vessel Collat, Shijiazhuang 050035, Peoples R China.

HELIYON, 2023; 9 (7):

Abstract

Aims: To explore the new indications and key mechanism of Bazi Bushen capsule (BZBS) by network pharmacology and in vitro experiment.Methods: The ingr......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Repositioning of clinically approved drug Bazi Bushen capsule for treatment of Aizheimer's disease using network pharmacology approach and in vitro experimental validation

科室

工具

服务